galantamin mylan 8 mg depotkapseli, kova
mylan ab - galantamini hydrobromidum - depotkapseli, kova - 8 mg - galantamiini
galantamin mylan 16 mg depotkapseli, kova
mylan ab - galantamini hydrobromidum - depotkapseli, kova - 16 mg - galantamiini
galantamin mylan 24 mg depotkapseli, kova
mylan ab - galantamini hydrobromidum - depotkapseli, kova - 24 mg - galantamiini
padcev
astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - antineoplastiset aineet - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.
seloken zoc 23.75 mg depottabletti
astrazeneca oy - metoprololi succinas - depottabletti - 23.75 mg - metoprololi
seloken zoc 95 mg depottabletti
recordati ireland ltd. - metoprolol succinate - depottabletti - 95 mg - metoprololi
seloken zoc 190 mg depottabletti
recordati ireland ltd. - metoprolol succinate - depottabletti - 190 mg - metoprololi
seloken zoc 47.5 mg depottabletti
recordati ireland ltd. - metoprolol succinate - depottabletti - 47.5 mg - metoprololi
removab
neovii biotech gmbh - catumaxomab - ascites; cancer - muut antineoplastiset aineet - removab on tarkoitettu pahanlaatuisten ascitesin intraperitoneaaliseen hoitoon potilailla, joilla on epcam-positiiviset karsinoomat, joissa standardihoitoa ei ole saatavilla tai ei enää ole mahdollista.
antabus 200 mg poretabletti
teva b.v. - disulfiram - poretabletti - 200 mg - disulfiraami